Growth Metrics

Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025)

Kestra Medical Technologies (KMTS) reported Preferred Stock Liabilities of $280.5 million for Q1 2025, up 58.38% on a QoQ basis from $177.1 million in Q2 2024.

Kestra Medical Technologies (KMTS) has 2 years of Preferred Stock Liabilities data on file, last reported at $280.5 million in Q1 2025.

  • Quarterly Preferred Stock Liabilities changed N/A year-over-year to $280.5 million in Q1 2025, while the trailing twelve-month figure through Jan 2025 was $280.5 million (changed N/A YoY) and the FY2024 annual result came in at $177.1 million, changed N/A from the prior year.
  • Preferred Stock Liabilities grew to $280.5 million in Q1 2025 per KMTS's latest filing, from $177.1 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $280.5 million in Q1 2025 and bottomed at $177.1 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Kestra Medical Technologies 1.13 Bn 840.05 Mn 12.91 Mn -

Historic Data

Download Data 🔒
DateValue
Jan 31, 2025 280.51 Mn
Apr 30, 2024 177.11 Mn